Results - Announcements
Laurus Labs Ltd share price gained 2.75% to Rs 2245.0 after the company's net profit surged by 20.65% to Rs 436.74 crore, while revenue from operations slightly gained 8.89% to Rs 2206.37 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, rising 4.44%. It has improved by 5.74% over last one week and gained upto 0.60% in last one month while the market capitalization of Laurus Labs Ltd has increased 13.73% and 23.62% in the same period respectively.
Profit before tax (PBT) of Laurus Labs Ltd stood at Rs 591.82 crore in Q3 FY26, rallying 119.41% year-on-year, and surging by 22.95% quarter-on-quarter. EBITDA came in at Rs 737 crore, jumping 95.93% YoY and expanding by 17.20% sequentially.
Total expenses inched up 4.73% to Rs 1583.46 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 900.69 crore, increasing 14.63% YoY, while employee benefits expense was at Rs 265.71 crore, ticking higher by 2.71% YoY.
For the TTM ended FY26, revenue from operations surged 22.67% to Rs 6812.9 crore, while net profit soared by 151.08% to Rs 889.85 crore, compared to previous TTM. EBITDA jumped by 102914% to Rs 1722.76 crore, and PBT jumped 144.04% to Rs 1181.88 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 1623.5 crore in FY26, as against Rs 601.65 crore in FY25.
Laurus Labs Ltd rallied 133.49% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 12.76% during the same period.